Bain and Company’s Thomas Shin got together with Andy Choi, Dr. Jeffrey Roh  to interact with startups in one of Seoul VC Connect’s five Bootcamp sessions. Operated by the Seoul Metropolitan Government and G3 Partners, Seoul VC Connect supports Seoul-based startups in their international fundraising goals. 

Check out the full Bootcamp session with Tom Shin here

Director of New Ventures at Johnson & Johnson Innovation Stephen Lee talks Venture Funds

Strong Ven tures Co-Founder John Nam on International Expansion and Startup Mistakes

Silicon Valley-based VC Jay Eum talks International Fundraising

Early Stage Investor Eunse Lee talks Corporate Partnerships and Investments

Thomas Shin is a senior partner based in Bain & Company’s Seoul office and serves as the leader of the firm’s Organization practice in Korea. He is an expert in the global Advanced Manufacturing & Services, Chemicals, Energy & Natural Resources and Infrastructure, Construction & Building Products practices. He is also a global steering committee member of Bain’s Results Delivery® Group.

He has more than 25 years of industry and consulting experience, both in the United States and Korea.

Thomas has advised clients in a broad range of industries, including industrial goods and services, telecommunications, electronics, healthcare, consumer products and retail. His functional experience includes developing and implementing strategy, growth, business transformation and turnaround strategies; valuation, restructuring and transformation and assessing market opportunities for multinational and Korean companies (both inbound and outbound). He also is spearheading the creation of  eco-systems in Korea to serve the diverse growing needs of clients in this time of digital transition.

“Help others succeed. Think it, do it, live it for all of our clients, colleagues, direct reports and everyone we touch every day, every hour.”Thomas Shin

Thomas served as Bain Seoul’s office head from 2002 to 2010. He serves and advises many of the top Korean chaebols and executives, as well as foreign multinational corporations.

Prior to joining Bain, Thomas was the founder and Managing Director of another management consulting firm in Korea.

Thomas holds an MBA from University of Chicago and graduated magna cum laudefrom Columbia University with a bachelor’s degree in economics.

CEO, Amplify Surgical and Co-Founder, Partner, Board of  Directors

IntuitiveX

Mr. Choi has over 20 years of experience in product development and commercialization with expertise in the medical device industry. He has held executive positions ranging from engineering to marketing and sales in start-up settings to Fortune 500 companies.

Prior to co-founding Amplify Surgical, Mr. Choi was the Chief Business Development Officer at CTL and the VP of R&D at Ellipse Technologies and VertiFlex. While at VertiFlex, he introduced a pioneering minimally-invasive technology, enabling interventional physicians to surgically treat lumbar spinal stenosis. He also led the development and the asset sale of a spinal fusion system to Stryker, achieving a 10x return in less than a year from concept to commercialization. For almost 10 years, Mr. Choi also held leadership positions in both marketing and engineering with Stryker Spine and Orthopedics.

Mr. Choi earned his B.S. in Mechanical Engineering from U.C. Berkeley and received his MBA from Rutgers University. He also completed executive education program from the Wharton School of the University of Pennsylvania

Director of Minimally Invasive Spine Surgery, Swedish Neuroscience Institute

Chairman, Swedish Hospital’s Integrated Spine Program

Dr. Roh has over fifteen years of experience as an inventor, angel investor, and serial entrepreneur and holds multiple patents through the USPTO. He is a Co-Founder of IntuitiveX, a Seattle-based life science incubator.

He currently serves as a consultant on Stryker corporation’s Surgical Design and Innovation team and was instrumental in the development of their most commercially successful minimally invasive spine system of all time, ES2, as well as their marquee lateral access platform, ARIA.

Dr. Roh currently serves as the Director of Minimally Invasive Spine Surgery at the Swedish Neuroscience Institute, is the Chair of the Seattle Science Foundation’s annual Minimally Invasive Spine Symposium, and serves as a consultant on Providence Venture’s Strategy & Innovation team.

He completed his orthopedic surgery residency at Case Western Reserve University and his spine surgery fellowship at the Hospital for Special Surgery in NYC. He is a graduate of the Michael G. Foster School of Business MBA program at the University of Washington and received a Master of Science in Technology Management at Columbia University in NYC.